Detalhe da pesquisa
1.
HER2-low and tumor infiltrating lymphocytes in triple-negative breast cancer: Are they connected?
Breast Cancer Res
; 26(1): 41, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468323
2.
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort.
Mod Pathol
; 36(4): 100087, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788086
3.
Interobserver Variation in the Assessment of Immunohistochemistry Expression Levels in HER2-Negative Breast Cancer: Can We Improve the Identification of Low Levels of HER2 Expression by Adjusting the Criteria? An International Interobserver Study.
Mod Pathol
; 36(1): 100009, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36788064
4.
Elastin in pulmonary pathology: relevance in tumours with a lepidic or papillary appearance. A comprehensive understanding from a morphological viewpoint.
Histopathology
; 80(3): 457-467, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355407
5.
Corrigendum to "HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort" [Modern Pathology 36(4) 100087].
Mod Pathol
; 36(12): 100356, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951019
6.
HER2-low breast cancer and response to neoadjuvant chemotherapy: a population-based cohort study.
Pathology
; 56(3): 334-342, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341307
7.
Selecting patients with HER2-low breast cancer: Getting out of the tangle.
Eur J Cancer
; 175: 187-192, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36137393